maps.org Report : Visit Site

Technical data of the maps.org

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host maps.org. Currently, hosted in United States and its service provider is Amazon Technologies Inc. .

the related websites

local.google.co.uk tfl.gov.uk nationalrail.co.uk ordnancesurvey.co.uk dash4it.co.uk promap.co.uk old-maps.co.uk metrobus.co.uk talkytoaster.me.uk google.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

about research news resources participate donate store search ... go what is maps? founded in 1986, the (maps) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. donate stay connected your email address: psychedelic peer support: donate to the zendo project make a donation to the zendo project to help transform difficult psychedelic experiences at festivals and events. featured media video: oslo freedom forum 2018: rick doblin, ph.d. "i'm here to say that there is new hope for the treatment of trauma," begins maps founder rick doblin, ph.d., at the oslo freedom forum in oslo, norway, on may 29, 2018. "this hope is coming from a psychedelic drug called mdma." psychiatry advisor: mdma-assisted psychotherapy effective for treating ptsd in veterans, first responders "the investigators contend that this trial provides further evidence that mdma-assisted psychotherapy is safe and effective for treating patients with chronic ptsd. as a result of 6 phase 2 trials, the fda has designated mdma-assisted psychotherapy for ptsd as breakthrough therapy," reports laurel ranger of psychiatry advisor . ending america's war on drugs would finally unleash the therapeutic potential of psychedelics time publishes a new article by maps founder rick doblin, ph.d., outlining how current drug policies create barriers to psychedelic research that has potential to heal trauma. featured media how mdma went from club drug to 'breakthrough therapy wall street journal magazine | october 18, 2017 mdma advances another step as tool to treat ptsd american psychiatric association | october 20, 2017 lucy in the sky with doctors the boston globe | october 14, 2017 -- december 8-10: australia entheogenesis australis 2017 attend australia's premier psychedelic symposium -- our work mdma-assisted psychotherapy our highest priority project is funding clinical trials of 3,4-methylenedioxymethamphetamine (mdma) as a tool to assist psychotherapy for the treatment of posttraumatic stress disorder (ptsd). we are also sponsoring ongoing clinical trials of mdma-assisted psychotherapy for anxiety associated with life-threatening illness, and mdma-assisted therapy for social anxiety in autistic adults. preliminary studies have shown that mdma in conjunction with psychotherapy can help people overcome ptsd, and possibly other disorders as well. lsd-assisted psychotherapy in 2014, maps completed the first double-blind, placebo-controlled study of the therapeutic use of lsd in human beings since the early 1970s. maps is interested in lsd for its potential to help people with a variety of conditions, focusing primarily on the treatment of anxiety associated with life-threatening illness. our phase 2 pilot study in 12 subjects found positive trends in the reduction of anxiety following two lsd-assisted psychotherapy sessions. the study results also indicate that lsd-assisted psychotherapy can be safely administered in these subjects, and justify further research. ibogaine therapy for drug addiction maps-sponsored researchers have published observational data from the first prospective ibogaine outcome studies in order to contribute to the growing scientific literature about ibogaine as a treatment for drug addiction. although first-hand accounts indicate that ibogaine is not popular as a recreational drug, ibogaine remains classified as a schedule i drug in the united states (it is also scheduled in belgium and switzerland). yet despite its classification as a drug with a "high potential for abuse" and "no currently accepted medical use," people who struggle with substance abuse continue to seek out international clinics or underground providers to receive ibogaine treatment. ayahuasca-assisted treatment maps supports research into the safety and effectiveness of ayahuasca-assisted treatment for drug addiction and ptsd. we also support conferences, meetings, and publications about the scientific, therapeutic, sustainable, and spiritual uses of ayahuasca. we also serve as non-profit fiscal sponsor for organizations that support these uses. we recently completed the first north american observational study of the safety and long-term effectiveness of ayahuasca treatment for addiction and dependence. the paper describing the results of the study was published in june 2013 in current drug abuse reviews . medical marijuana maps has been working since 1992 to sponsor fda-approved clinical studies into the safety and efficacy of botanical marijuana as a prescription medicine for specific medical uses. we've obtained approval from fda and from institutional review boards for several different protocols but were unable to obtain approval to purchase federally-legal marijuana from the national institute on drug abuse (nida). on march 14, 2014, the u.s. public health service approved our request to purchase nida marijuana for our study of smoked whole plant (botanical) marijuana for symptoms of ptsd in u.s. veterans, an historic shift in federal policy. on december 17, 2014, maps was awarded a $2.15 million grant from the colorado department of public health and environment to conduct the study. the ongoing study has received full approval from the fda, dea, and institutional review boards (irbs). zendo project: psychedelic peer counseling the zendo project provides a supportive environment and specialized care at festivals and events, designed to transform difficult psychedelic experiences into valuable learning opportunities, and even potentially offer healing and growth. in turn, our work reduces the number of drug-related hospitalizations and arrests. our values transparency information is shared openly and clearly. communications are respectful, honest, and forthright. passion and perseverance we persist in the face of challenges. we have a sense of urgency about our work, and know that it's a long-term effort. intelligent risk our decisions are informed by research. we try new things and learn from our mistakes. trust and accountability we value integrity and honesty, and embrace high standards. maps we are a 501(c)(3) non-profit research and educational organization developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. watch videos from psychedelic science 2017 . media august 11, 2018 live science: these psychedelic drugs show promise for treating mental health disorders august 9, 2018 marijuana moment: study on marijuana and ptsd in military veterans only needs a few more volunteers august 9, 2018 press release: first clinical trial of marijuana for ptsd in veterans nearly completes enrollment about us mission board of directors staff financial reports maps public benefit corporation (mpbc) 501(c)(3) & bylaws faq contact us 1115 mission street santa cruz, ca 95060-9989 phone: 831-429-mdma (6362) fax: 831-429-6370 email: this email address is being protected from spambots. you need javascript enabled to view it. log in to your account creative commons 2018 privacy policy | donate search ... about mission board of directors staff financial reports maps public benefit corporation (mpbc) 501(c)(3), ein, and bylaws privacy policy faq research mdma-assisted psychotherapy lsd-assisted psychotherapy ibogaine therapy for drug addiction ayahuasca-assisted treatment medical marijuana other psychedelic research research articles news email newsletter maps bulletin maps in the media maps podcast multimedia library posts maps podcast resources brochures psychedelic harm reduction research papers psychedelic integration list psychedelic bibliography free books and essays links for students maps forums on bluelight psychedelic science 2017 videos participate global psychedelic dinners featured events event calendar volunteer global psychedelic dinners internships mdma therapy training program careers participat

URL analysis for maps.org

https://maps.org/resources/brochures
https://maps.org/resources/students
https://maps.org/research/mmj
https://maps.org/about/bylaws
https://maps.org/resources/responding-to-difficult-psychedelic-experiences
https://maps.org/news/media/7330-press-release-first-clinical-trial-of-marijuana-for-ptsd-in-veterans-nearly-completes-enrollment
https://maps.org/about/fiscal
http://maps.org/login
http://maps.org/donate
https://maps.org/research/ayahuasca
https://maps.org/news
https://maps.org/participate/featured-events
https://maps.org/news/media/7339-live-science-these-psychedelic-drugs-show-promise-for-treating-mental-health-disorders
https://maps.org/research/other-research
https://maps.org/resources

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: MAPS.ORG
Registry Domain ID: D3299163-LROR
Registrar WHOIS Server: http://api.fastdomain.com/cgi/whois
Registrar URL: http://www.fastdomain.com
Updated Date: 2017-07-23T04:00:07Z
Creation Date: 1994-07-24T04:00:00Z
Registry Expiry Date: 2018-07-23T04:00:00Z
Registrar Registration Expiration Date:
Registrar: FastDomain Inc.
Registrar IANA ID: 1154
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.6022262389
Reseller:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Registrant Organization: MAPS
Registrant State/Province: California
Registrant Country: US
Name Server: NS-1125.AWSDNS-12.ORG
Name Server: NS-21.AWSDNS-02.COM
Name Server: NS-789.AWSDNS-34.NET
Name Server: NS-1858.AWSDNS-40.CO.UK
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2018-06-22T21:09:13Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to (a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.

Please query the RDDS service of the Registrar of Record identified in this output for information on how to contact the Registrant, Admin, or Tech contact of the queried domain name.

  REFERRER http://www.pir.org/

  REGISTRAR Public Interest Registry

SERVERS

  SERVER org.whois-servers.net

  ARGS maps.org

  PORT 43

  TYPE domain

DOMAIN

  NAME maps.org

  HANDLE D3299163-LROR

  CREATED 1994-07-24

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  NS-1125.AWSDNS-12.ORG 205.251.196.101

  NS-21.AWSDNS-02.COM 205.251.192.21

  NS-789.AWSDNS-34.NET 205.251.195.21

  NS-1858.AWSDNS-40.CO.UK 205.251.199.66

OWNER

  ORGANIZATION MAPS

ADDRESS

  STATE California

  COUNTRY US

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .